Get new exclusive access to healthcare business reports & breaking news
Thorne HealthTech, a leader in developing innovative solutions for a personalized approach to health and wellbeing, announced, on September 22nd, the pricing of its initial public offering of 7,000,000 shares of its common stock at a price to the public of $10.00 per share. BofA Securities, Cowen, and Evercore ISI are acting as lead book-running managers for the proposed offering. RBC Capital Markets is acting as an additional book-running manager.
2020 has been the Year of Healthcare, with efforts to find new treatments to help patients all over the world survive the most serious pandemic Earth has seen. With the world rocked to its core by the COVID-19 threat, the planet’s population is talking about serology tests, vaccine development, clinical trials, medical capacity, and the role of governments in protecting or advancing public health.
Big data has been key in adapting businesses and everyday life to the prerequisites of the Information Age, and also to working remotely. Now that we have the technology to process large amounts of data quickly, there is no limit to the number of applications for data analysis across industries. Healthcare, especially, is ready for advancement through the use of big data.
Since there are still too many things we do not yet know about human health and how to treat certain diseases, the healthcare industry still has too much space for waste and errors, thus being perfect to implement some new AI assisted solutions.
Data can be a huge help in not only making the healthcare industry more efficient but also in advancing medical research. Pioneering new treatments and improving patient care has become easier by using the vast amount of data already collected in the healthcare industry.
Healthcare has been at the beating heart of innovation, tech, and policy even before the COVID-19 crisis. Billions of investment dollars pour into med tech startups and industry giants, racing to implement cutting-edge technologies to revolutionize the healthcare industry.
People want to know more about healthcare, especially directly from the industry’s leadership, and thought leaders in this field have rushed to fill that demand through podcasts, a low-tech and inexpensive way to talk to huge global audiences. And the audiences are really extensive. Over 90% of Americans have listened to a podcast in the last 12 months, and few subjects are more talked about than healthcare.
Podcasts are available through free listening services like Apple Podcasts, Spotify, and Stitcher. They are a way for people to educate themselves, while commuting or doing everyday house tasks, listeners immersing themselves in hours and hours of content, thus becoming a more informed populace, with an attention span for long-form content.
Representing the perspective of laypeople, marketers, doctors and nurses, academics, policy makers, investors, inventors, innovators, and many more, the conversation about healthcare thrives over RSS feeds. Here are the 19 healthcare podcasts you should be listening to in 2021.
It is very important to understand the context in which IPO’s like this of Thorne HealthTech are made.
Thorne HealthTech, a science-driven, vertically integrated wellness platform built to deliver best-in-class, end-to-end nutritional solutions and health intelligence, is relatively new on the market. Thorne, a health and technology company seeking to disrupt the prevention and wellness market, announced February 25th it has merged with Onegevity, a health intelligence company with a proprietary, multi-omic platform that leverages artificial intelligence (AI) and machine learning to map, integrate, and understand the billions of dynamic and biological features that showcase the state of an individual’s health.
Thorne HealthTech has granted the underwriters a 30-day option to purchase up to an additional 1,050,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Thorne HealthTech, are expected to be $70.0 million, excluding any exercise of the underwriters’ option to purchase additional shares.
The shares began trading on the Nasdaq Global Select Market on September 23, 2021, under the ticker symbol “THRN,” and the offering is expected to close on September 27, 2021, subject to customary closing conditions.
A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on September 22, 2021. The offering is being made only by means of a prospectus.
When available, copies of the final prospectus relating to the initial public offering may be obtained from: BofA Securities, NC1-004-03-43, 200 North College Street, 3rd floor, Charlotte NC 28255-0001, Attn: Prospectus Department; Email: [email protected]; Cowen and Company, LLC, c/o Broadridge Financial Solutions, Attention: Prospectus Department, 1155 Long Island Avenue, Edgewood, NY 11717, by email at [email protected] or by telephone at (833) 297-2926; or Evercore Group L.L.C., Attention: Equity Capital Markets, 55 East 52nd Street, 35th Floor, New York, NY 10055, by email at [email protected] or by telephone at (888) 474-0200.
Thorne HealthTech is a leader in developing innovative solutions for a personalized approach to health and wellbeing. Thorne HealthTech is a science-driven wellness company that is utilizing testing and data to create improved product efficacy and deliver personalized solutions to consumers, health professionals, and corporations. Thorne HealthTech’s unique, vertically integrated brands, Thorne and Onegevity, provide insights and personalized data, products, and services that help individuals take a proactive and actionable approach to improve and maintain their health over a lifetime.